Sorafenib 200mg (Cipla)
Being a customer oriented firm, we are counted among the well known exporters and suppliers of premium grade Sorafenib 200mg (Cipla). This tablet is consumed across the globe in chemotherapy of kidney, liver and thyroid cancer. Ideal to be taken on an empty stomach at least 1 to 2 hours after a food, the tablet is formulated using top grade sorafenib as an active ingredient. Offered Sorafenib 200mg (Cipla) is available in packaging of 30 tablets.
- Works by slowing the growth of new blood vessels within the tumor
- Safe to consume
- Has common side effects like acne, fatigue, loss of appetite, weight loss etc.
- Main Export Market(s)
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia